Novel biosensor-based analytic device for the detection of anti-double-stranded DNA antibodies

Clinical Chemistry

Volumn 53, Issue 2, 2007, Pages 334-341

  Buhl, Alexander ^a   Metzger, Jochen H ^a   Heegaard, Niels H H ^b   Von Landenberg, Philipp ^c   Fleck, Martin ^d   Luppa, Peter B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; OLIGONUCLEOTIDE; RECOMBINANT DNA; TRANSFERRIN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGENIC MODULATION; ARTICLE; BINDING AFFINITY; BIOSENSOR; BIOTINYLATION; BLOOD ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA BINDING; DNA DETERMINATION; DNA MICROARRAY; HUMAN; HUMAN CELL; METHODOLOGY; NUCLEIC ACID IMMOBILIZATION; STATISTICAL ANALYSIS; SURFACE PLASMON RESONANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; BIOSENSING TECHNIQUES; DNA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE;

EID: 33847338906     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.077339     Document Type: Article

References (25)

1. Kotzin BL. Systemic lupus erythematosus. Cell 1996;85:303-6.
2. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003;56:481-90.
3. Manzi S. Epidemiology of systemic lupus erythematosus. Am J Manag Care 2001;7 (16 Suppl):474-9.
4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
6. Cervera R, Khamashta MA, Font J, Sebastian: GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993;72:113-24.
7. Hahn BH. Antibodies to DNA. N Engl J Med 1998;338:1359-68.
8. Swaak T, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 1985;44:245-51.
9. Bootsma H, Spronk PE, Ter Borg EJ, Hummel EJ, de Boer G, Limburg PC, et al. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus: a prospective long term observation. Ann Rheum Dis 1997;56:661-6
10. Förger F, Matthias T, Oppermann M, Becker H, Helmke K. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 2004;13:36-44.
11. Isenberg D, Smeenk R. Clinical laboratory assays for measuring anti-dsDNA antibodies: where are we now? Lupus 2002;11:797-800.
12. Rahman A, Hiepe F. Anti-DNA antibodies-overview of assays and clinical correlations. Lupus 2002;11:770-3.
13. Cui Z, Zhao MH. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin Immunol 2005;116:77-82.
14. Cucnik S, Kveder T, Krizaj I, Rozman B, Bozic B. High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann Rheum Dis 2004;63:1478-82.
15. Winfield JB, Faiferman I, Koffler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. J Clin Invest 1977;59:90-6.
16. Villalta D, Romelli PB, Savina C, Bizzaro N, Tozzoli R, Tonutti E, et al. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus 2003;12:31-6.
17. Jönsson U, Malmqvist M. Real time biospecific interaction analysis, the integration of surface plasmon resonance detection, general biospecific interface chemistry and microfluidics into one analytical system. Adv Biosensors 1992;2:291-336.
18. Van Regenmortel MH, Altschuh D, Chatellier J, Christensen L, Rauffer-Bruyere N, Richarlet-Secordel P, et al. Measurement of antigen-antibody interactions with biosensors. J Mol Recognit 1998;11:163-7.
19. Heegaard NH, Olsen DT, Larsen KL. Immuno-capillary electrophoresis for the characterization of a monoclonal antibody against DNA. J Chrom A 1996;744:285-94.
20. Kozlov IA, Melnyk PC, Stromsborg KE, Chee MS, Barker DL, Zhao C. Efficient strategies for the conjugation of oligonucleotides to antibodies enabling highly sensitive protein detection. Biopolymers 2004;73:621-30.
21. Deng JS, Sontheimer RD, Lipscomb MF, Gilliam JN. The binding of antihistone antibodies to crithidia luciliae kinetoplasts is growth cycle-dependent. Arthritis Rheum 1985;28:163-8.
22. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000;53:424-32.
23. Reveille JD. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 2004;13:290-7.
24. Frankfurt OS. Detection of DNA damage in individual cells by flow cytrometric analysis using anti-ssDNA monoclonal antibody. Exp Cell Res 1987;170:369-80.
25. Frankfurt OS. Decreased DNA stability in the cells treated with alkylating agents. Exp Cell Res 1990;191:181-5.